Literature DB >> 20495740

Enhanced chemoresistance and tumor sphere formation as a laboratory model for peritoneal micrometastasis in epithelial ovarian cancer.

Olga Soriţău1, C I Tomuleasa, Emöke Páll, Piroska Virág, Eva Fischer-Fodor, V Foris, Otilia Barbos, Corina Tatomir, G Kacsó, A Irimie.   

Abstract

BACKGROUND AND
PURPOSE: Ovarian cancers are composed of heterogeneous cell populations, including highly proliferative immature precursors and differentiated cells that may belong to different lineages. The main reason why epithelial ovarian cancer is difficult to treat is the unusual mechanism of dissemination that involves local invasion of pelvic and abdominal organs. But, unlike many other carcinomas, initial dissemination rarely requires blood or lymph vessels. Because it has been proven that aggregates of malignant cells within the ascites of patients diagnosed with ovarian cancer represent an impediment to cure such cancers, in the present study we adopted suspension culture combined with anti-cancer regimens as a laboratory strategy for research of the initial process of peritoneal micrometastasis. EXPERIMENTAL
DESIGN: MLS human ovarian cancer cells were cultured in serum-free medium. Cells of passage eight were treated in combination with the anticancer agent doxorubicin at different peak plasma concentrations for 24 hours, and then maintained under suspension culture. The acquired increased aggressiveness properties was confirmed by multidrug resistance assays and by their ability to grow in an anchorage-independent manner in vitro as tumor spheroids.
RESULTS: Cells selected after chemotherapy had a increased proliferative potential, eliminated Rhodamine 123 in culture and also formed spheroids in suspension.
CONCLUSIONS: Here we present direct evidence that the metastasis of human ovarian cancer may be a result of transformation and dysfunction of immature precursor cells in the ovary. Also, spheroid formation may represent a key component of chemotherapy recurrence and a better understanding of these 3D structures can contribute to the development of new treatments for metastatic carcinoma.

Entities:  

Mesh:

Year:  2010        PMID: 20495740

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  8 in total

Review 1.  Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.

Authors:  Xiaoxiang Chen; Jing Zhang; Zhihong Zhang; Hongxia Li; Wenjun Cheng; Jinsong Liu
Journal:  Hum Pathol       Date:  2013-07-11       Impact factor: 3.466

2.  Evaluation of stem cell properties in human ovarian carcinoma cells using multi and single cell-based spheres assays.

Authors:  Hui Wang; Anna Paczulla; Claudia Lengerke
Journal:  J Vis Exp       Date:  2015-01-03       Impact factor: 1.355

3.  Alteration of microRNA profiling in sphere-cultured ovarian carcinoma cells.

Authors:  Hwa Jun Cha; Sung Kwan An; Tae Jin Kim; Jae Ho Lee
Journal:  Oncol Lett       Date:  2018-05-25       Impact factor: 2.967

4.  Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy.

Authors:  Bobe Petrushev; Sanda Boca; Timea Simon; Cristian Berce; Ioana Frinc; Delia Dima; Sonia Selicean; Grigore-Aristide Gafencu; Alina Tanase; Mihnea Zdrenghea; Adrian Florea; Sorina Suarasan; Liana Dima; Raluca Stanciu; Ancuta Jurj; Anca Buzoianu; Andrei Cucuianu; Simion Astilean; Alexandru Irimie; Ciprian Tomuleasa; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2016-02-15

5.  Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression.

Authors:  Rafaela Erices; Sofía Cubillos; Raúl Aravena; Felice Santoro; Monica Marquez; Renan Orellana; Carolina Ramírez; Pamela González; Patricia Fuenzalida; María Loreto Bravo; Bárbara Oliva; Sumie Kato; Carolina Ibañez; Jorge Brañes; Erasmo Bravo; Catalina Alonso; Karen García; Clemente Arab; Vicente A Torres; Alejandro S Godoy; Jaime Pereira; Galdo Bustos; Julio Cesar Cardenas; Mauricio A Cuello; Gareth I Owen
Journal:  Oncotarget       Date:  2017-03-28

Review 6.  Culture models to define key mediators of cancer matrix remodeling.

Authors:  Emily Suzanne Fuller; Viive Maarika Howell
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

Review 7.  Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.

Authors:  Mauricio Rodriguez-Torres; Alison L Allan
Journal:  Clin Exp Metastasis       Date:  2015-10-07       Impact factor: 5.150

8.  The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices.

Authors:  Dimakatso Alice Senthebane; Tina Jonker; Arielle Rowe; Nicholas Ekow Thomford; Daniella Munro; Collet Dandara; Ambroise Wonkam; Dhirendra Govender; Bridget Calder; Nelson C Soares; Jonathan M Blackburn; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2018-09-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.